http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101070587-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-04 |
| filingDate | 2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101070587-B1 |
| titleOfInvention | (2S, 3S) -3-[[(1S) -1-isobutoxymethyl-3-methylbutyl] carbamoyl] oxirane 2-carboxylic acid salt |
| abstract | The present invention relates to (2S, 3S) -3-[[(1S) -1-isobutoxymethyl-3-methylbutyl using a salt from a carboxylic acid and an organic amine selected from piperazine, adamantaneamine and the like. ] Carbamoyl] -oxirane-2-carboxylic acid (hereinafter referred to as " carboxylic acid "), and a carboxylic acid suitable for use as a raw material for pharmaceuticals having the following properties and having enhanced storage stability The present invention relates to the provision of crystalline sodium salts.n n n DSC: exothermic peak with weight loss observed at 170-175 ° C .; Andn n n Characteristic absorption bands of the infrared absorption spectrum (tablet bromide tablet): 3255, 2950, 2860, 1670, 1630, 1550, 1460, 1435, 1395, 1365, 1310, 1260, 1110, 890 cm −1 . |
| priorityDate | 2003-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.